Argent Biopharma Limited (RGT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,873 | 2,354 | 9,859 | 11,364 | 7,896 |
| Receivables | 407 | 1,140 | 469 | 608 | 360 |
| Inventories | 495 | 246 | 712 | 508 | 157 |
| Other current assets | 363 | 0 | 0 | 0 | 500 |
| TOTAL | $3,323 | $3,827 | $11,504 | $12,485 | $9,030 |
| Non-Current Assets | |||||
| PPE Net | 4,253 | 1,470 | 1,334 | 1,258 | 211 |
| Investments And Advances | 674 | 2,772 | N/A | N/A | N/A |
| Intangibles | N/A | 5,034 | 7,083 | 7,076 | 7,084 |
| Other Non-Current Assets | 674 | 2,772 | 73 | 0 | 36 |
| TOTAL | $5,600 | $12,048 | $8,490 | $8,335 | $7,331 |
| Total Assets | $8,924 | $15,876 | $19,994 | $20,820 | $16,361 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,075 |
| Accounts payable and accrued liabilities | 2,706 | 1,165 | 809 | 465 | 145 |
| Other current liabilities | 109 | N/A | 6,270 | 4,370 | 3,080 |
| TOTAL | $3,672 | $2,181 | $7,231 | $4,966 | $4,612 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 22 | 20 | 20 |
| Deferred Revenues | 100 | 588 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 31 | 178 | 1,245 | 445 | 81 |
| TOTAL | $1,865 | $17 | $73 | $65 | $20 |
| Total Liabilities | $5,537 | $2,199 | $7,303 | $5,031 | $4,632 |
| Shareholders' Equity | |||||
| Common Shares | 60,149 | 49,134 | 48,441 | 42,557 | 32,343 |
| Retained earnings | -62,128 | -41,465 | -38,030 | -29,784 | -21,640 |
| Other shareholders' equity | 5,084 | 3,290 | 3,522 | 3,460 | 1,106 |
| TOTAL | $3,105 | $10,959 | $13,933 | $16,233 | $11,810 |
| Total Liabilities And Equity | $8,642 | $13,158 | $21,236 | $21,264 | $16,442 |